Macrophages are white blood cells of the innate immune system that engulf and digest microbes, dead cells and debris. They also release signals that start inflammation, help end it, and guide tissue repair, and they change what they do according to the signals around them.[1] Macrophage size differs between tissues and species: alveolar macrophages washed from the lungs of 10 healthy non-smoking volunteers averaged about 21 micrometres in diameter, against about 13 micrometres in rats and hamsters, measured by an electronic cell-volume method.[2]
Dendritic Cells and Macrophages (VIDEO)
Macrophages are part of the innate immune system, which responds early to invasion by viruses and bacteria, together with physical barriers such as the skin and other immune cells such as neutrophils. Macrophages help protect tissues by engulfing and killing many types of bacteria.
Monocytes are made in the bone marrow, circulate in the blood and move into tissues, where they can become macrophages.[1] Many tissues also have their own resident macrophages with local names: Kupffer cells in the liver, microglia in the brain, alveolar macrophages in the lungs and osteoclasts in bone.[1] Newer methods for tracing where cells come from overturned the old view that adult macrophages are constantly replaced by bone marrow monocytes: several resident populations are seeded during blood formation in the embryo and then maintain themselves in adult tissue independently of the bone marrow, although how they do so is not yet understood.[3]
Macrophage activation is usually described with two labels. Classically activated (M1) macrophages fight microbes and drive inflammation; alternatively activated (M2) macrophages are linked to wound healing, tissue repair and immune regulation. These labels are a simplification: macrophages show a spectrum of states that blend into each other.[1] An international group of researchers recommended naming activated macrophages after the signal used to activate them, such as M(IFN-γ), M(LPS) or M(IL-4), rather than as M1 or M2.[4]
M1 Macrophages (Classically Activated):
Classical activation follows exposure to interferon-gamma together with tumor necrosis factor (TNF) or a microbial signal such as bacterial lipopolysaccharide (LPS), which acts through toll-like receptors and itself switches on TNF production. The activated cells kill microbes more efficiently, release large amounts of pro-inflammatory cytokines and carry more co-stimulatory molecules on their surface.[1]
Markers associated with classical activation:
- Cytokines: IL-1, IL-6, IL-12 and IL-23, with TNF[1]
- Chemokines: CXCL9, CXCL10 and CXCL11, induced by interferon-gamma[1]
- Enzyme: inducible nitric oxide synthase (iNOS), which makes nitric oxide to kill microorganisms[1]
- Surface: the co-stimulatory molecules CD80 and CD86, which are also high on regulatory macrophages, so they do not identify M1 cells on their own[1]
Fractalkine (CX3CL1) is a chemokine, not an M1 marker. What separates monocyte subsets is how much of its receptor, CX3CR1, they carry: in mice, monocytes with low CX3CR1 are recruited to inflamed tissue and those with high CX3CR1 move into non-inflamed tissue, and the same receptor levels separate the two main human monocyte subsets, CD14+CD16- and CD14lowCD16+.[5]
M2 Macrophages (Alternatively Activated)
Alternative activation follows exposure to IL-4 or IL-13. These macrophages express the mannose receptor CD206 and the IL-4 receptor alpha chain.[1] A separate regulatory state is defined above all by high production of the anti-inflammatory cytokine IL-10 and low IL-12, so the ratio of IL-10 to IL-12 is often used to describe it.[1]
- Surface: CD206 (mannose receptor)[1]; CD163, found on resident macrophages in almost all normal human tissues[6]
- Cytokine: IL-10, the defining product of regulatory macrophages[1]
- Markers used mainly in mice: arginase-1 and Ym1 mark alternatively activated cells in mice but not in humans[7], and RELMα (FIZZ1) is strongly induced by IL-4[1]
Many markers worked out in mouse macrophages do not carry over to human macrophages, in part because human cells are usually grown from blood monocytes while mouse cells come from bone marrow or tissues.[4]
Markers Used to Identify Macrophages
Markers are measured on single cells by flow cytometry or in tissue sections by antibody staining (immunohistochemistry). None is perfect:
- CD68: widely used to stain macrophages in human tissue, but less specific than CD163, which is more closely limited to the monocyte and macrophage lineage.[6]
- CD14: high on the main subset of human blood monocytes, the cells that give rise to many macrophages.[5]
- F4/80: a standard marker of mouse macrophages. Its human counterpart, EMR1, is not found on human monocytes or macrophages; it is specific to eosinophils.[8]
How Mesenchymal Stromal Cells Shift Macrophages Toward Repair
Mesenchymal stromal cells (MSCs) push macrophages toward the alternatively activated, regulatory end of the spectrum, at least in the laboratory and in animals. When human macrophages grown from blood monocytes were cultured with human bone marrow MSCs for three days, they carried high levels of CD206, made more IL-10 and less IL-12, and engulfed particles more actively; they also made more IL-6 and less TNF.[9] In mice with sepsis, MSCs released prostaglandin E2, which made the animals’ own macrophages produce more IL-10; the mice survived better, and the benefit disappeared when macrophages were removed or IL-10 was blocked.[10]
This shift is one of the mechanisms proposed for MSC treatments, and the other mechanisms, with the human trial results, are set out on our page on immunomodulation. How macrophages take part in normal inflammation and healing is described on our page on inflammation and healing.
Published Clinical Citations
[1] ^ Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008;8(12):958-969. https://doi.org/10.1038/nri2448
[2] ^ Krombach F, Münzing S, Allmeling AM, et al. Cell size of alveolar macrophages: an interspecies comparison. Environmental Health Perspectives. 1997;105(Suppl 5):1261-1263. https://doi.org/10.1289/ehp.97105s51261
[3] ^ Ginhoux F, Guilliams M. Tissue-resident macrophage ontogeny and homeostasis. Immunity. 2016;44(3):439-449. https://doi.org/10.1016/j.immuni.2016.02.024
[4] ^ Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14-20. https://doi.org/10.1016/j.immuni.2014.06.008
[5] ^ Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71-82. https://doi.org/10.1016/s1074-7613(03)00174-2
[6] ^ Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. American Journal of Clinical Pathology. 2004;122(5):794-801. https://doi.org/10.1309/QHD6-YFN8-1KQX-UUH6
[7] ^ Raes G, Van den Bergh R, De Baetselier P, et al. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. Journal of Immunology. 2005;174(11):6561-6562. https://doi.org/10.4049/jimmunol.174.11.6561
[8] ^ Hamann J, Koning N, Pouwels W, et al. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor. European Journal of Immunology. 2007;37(10):2797-2802. https://doi.org/10.1002/eji.200737553
[9] ^ Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Experimental Hematology. 2009;37(12):1445-1453. https://doi.org/10.1016/j.exphem.2009.09.004
[10] ^ Németh K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine. 2009;15(1):42-49. https://doi.org/10.1038/nm.1905